Altria Stock Outperformed in a Rough Week, With DC Still in Focus
Altria surged 2.25% to $72.19 Friday—defying a 2.6% S&P 500 drop—as investors weighed Senate scrutiny over FDA vape policy and a looming June 15 dividend cutoff; the stock gained 3.8% for the week, sits 3% below its 52-week high, and reaffirmed 2026 EPS guidance of $5.56–$5.72.